Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART)

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

JETi 6F and 8F Thrombectomy system

To demonstrate the efficacy and safety of the mechanical thrombectomy device (JETi 6F and 8F) for treatment of patients with symptomatic peripheral artery disease (PAD) due to acute or acute on chronic occlusions of the femoral and/or popliteal arteries and the first 10 cm of the below-the -knee arteries.

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

ID3 Medical

OTHER

collaborator

Abbott

INDUSTRY

lead

Vascular Science LP GmbH

OTHER

NCT06434779 - Investigating Efficacy and Safety of JETi® in Arterial Occlusions in FEM-POP and Prox BTK-Lesions (JETART) | Biotech Hunter | Biotech Hunter